MABA for Autism Spectrum Disorder
Study Summary
This trial is studying a less intensive form of behavior intervention for autism spectrum disorder (ASD) to see if it is effective and causes less stress for parents.
- Autism Spectrum Disorder
- Autism
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are individuals still being accepted into this research project?
"Unfortunately, this particular clinical trial is not presently looking for patients according to the latest information available on clinicaltrials.gov. This page was last edited on 11/7/2022 and originally posted on 8/22/2019. There are, however, 285 other trials that are actively seeking patients right now."
At how many different hospitals is this research project being conducted?
"There are several locations where this trial is being conducted, they include: May Institute in Jacksonville, North Carolina; Nationwide Children's Hospital in Richmond, Virginia; Vanderbilt University Medical Center in Columbus, Tennessee."
Does this test only include elderly patients?
"This specific medical trial is only open to children between 18 months and 5 years old. Out of the 241 clinical trials available for minors, this one is unique in that it includes such a young age group. Additionally, there are 43 clinical trials total for patients over 65 years old."
How do I go about signing up for this clinical trial?
"Up to 60 individuals aged 18 months to 5 years old, who have a formal ASD diagnosis from an expert source, may participate. Patients must also not currently be receiving ABA services and meet the following additional criteria: (1) Confirmation by a research-reliable administration of the Autism Diagnostic Observation Schedule-2 (ADOS-2), OR confirmation by a routine clinical assessment and observation when a research-reliable ADOS-2 is not able to be collected due to COVID-19 restrictions, and (2) A symptom checklist based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Furthermore,"